Differential adeno-associated virus serotype-specific interaction patterns with synthetic heparins and other glycans

Journal of Virology

Volumn 88, Issue 5, 2014, Pages 2991-3003

  Mietzsch, Mario ^a   Broecker, Felix ^b,c   Reinhardt, Anika ^b,c   Seeberger, Peter H ^b,c   Heilbronn, Regine ^a  

^a CHARITÉ UNIVERSITÄTSMEDIZIN BERLIN   (Germany)

^b MAX PLANCK INSTITUTE OF COLLOIDS AND INTERFACES   (Germany)

^c FREIE UNIVERSITÄT BERLIN   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

GLYCAN; HEPARIN; PARVOVIRUS VECTOR; PROTEOHEPARAN SULFATE; SIALIC ACID;

ADENO ASSOCIATED VIRUS; ARTICLE; BINDING AFFINITY; CELL STRAIN HEK293; GENE MUTATION; GLYCOSYLATION; NONHUMAN; PRIORITY JOURNAL; PROTEIN CARBOHYDRATE INTERACTION; SEROTYPE; VIRUS ATTACHMENT; VIRUS CAPSID; VIRUS CELL INTERACTION; VIRUS PURIFICATION; VIRUS RECOMBINANT; VIRUS REPLICATION;

ANIMALS; CAPSID PROTEINS; CELL LINE; DEPENDOVIRUS; GENETIC VECTORS; HEPARAN SULFATE PROTEOGLYCANS; HEPARIN; HUMANS; MUTATION; POLYSACCHARIDES; PROTEIN ARRAY ANALYSIS; PROTEIN BINDING; RECEPTORS, VIRUS; SEROTYPING; STAINING AND LABELING; VIRUS ATTACHMENT;

EID: 84896730363     PISSN: 0022538X     EISSN: 10985514     Source Type: Journal    
DOI: 10.1128/JVI.03371-13     Document Type: Article

References (42)

1. Agbandje-McKenna M, Kleinschmidt J. 2011. AAV capsid structure and cell interactions. Methods Mol. Biol. 807:47-92. http://dx.doi.org/10 .1007/978-1-61779-370-7_3.
2. Summerford C, Samulski RJ. 1998. Membrane-associated heparan sulfate proteoglycan is a receptor for adeno-associated virus type 2 virions. J. Virol. 72:1438-1445.
3. Handa A, Muramatsu S, Qiu J, Mizukami H, Brown KE. 2000. Adenoassociated virus (AAV)-3-based vectors transduce haematopoietic cells not susceptible to transduction with AAV-2-based vectors. J. Gen. Virol. 81:2077-2084. http://vir.sgmjournals.org/content/81/8/2077.long.
4. Kaludov N, Brown KE, Walters RW, Zabner J, Chiorini JA. 2001. Adeno-associated virus serotype 4 (AAV4) and AAV5 both require sialic acid binding for hemagglutination and efficient transduction but differ in sialic acid linkage specificity. J. Virol. 75:6884-6893. http://dx.doi.org/10 .1128/JVI.75.15.6884-6893.2001.
5. Wu Z, Miller E, Agbandje-McKenna M, Samulski RJ. 2006. Alpha2,3 and alpha2,6 N-linked sialic acids facilitate efficient binding and transduction by adeno-associated virus types 1 and 6. J. Virol. 80:9093-9103. http: //dx.doi.org/10.1128/JVI.00895-06.
6. Bell CL, Vandenberghe LH, Bell P, Limberis MP, Gao GP, Van Vliet K, Agbandje-McKenna M, Wilson JM. 2011. The AAV9 receptor and its modification to improve in vivo lung gene transfer in mice. J. Clin. Invest. 121:2427-2435. http://dx.doi.org/10.1172/JCI57367.
7. Schmidt M, Govindasamy L, Afione S, Kaludov N, Agbandje-McKenna M, Chiorini JA. 2008. Molecular characterization of the heparindependent transduction domain on the capsid of a novel adeno-associated virus isolate, AAV(VR-942). J. Virol. 82:8911-8916. http://dx.doi.org/10 .1128/JVI.00672-08.
8. Bertozzi CR, Rabuka D. 2009. Structural basis of glycan diversity, p 23-36. InVarki A, Cummings RD, Esko JD, Freeze HH, Stanley P, Bertozzi CR, Hart GW, Etzler ME (ed), Essentials of glycobiology, 2nd ed. Cold Spring Harbor Press, Cold Spring Harbor, NY.
9. Benallal M, Anner BM. 1994. Identification of organ-specific glycosylation of a membrane protein in two tissues using lectins. Experientia 50: 664-668. http://dx.doi.org/10.1007/BF01952869.
10. Molinari M. 2007. N-glycan structure dictates extension of protein folding or onset of disposal. Nat. Chem. Biol. 3:313-320. http://dx.doi.org/10 .1038/nchembio880.
11. Zhao YY, Takahashi M, Gu JG, Miyoshi E, Matsumoto A, Kitazume S, Taniguchi N. 2008. Functional roles of N-glycans in cell signaling and cell adhesion in cancer. Cancer Sci. 99:1304-1310. http://dx.doi.org/10.1111 /j.1349-7006.2008.00839.x.
12. Nizet V, Esko JD. 2009. Bacterial and viral infections, p 537-552. In Varki A, Cummings RD, Esko JD, Freeze HH, Stanley P, Bertozzi CR, Hart GW, Etzler ME (ed), Essentials of glycobiology, 2nd ed. Cold Spring Harbor Press, Cold Spring Harbor, NY.
13. Dreyfuss JL, Regatieri CV, Jarrouge TR, Cavalheiro RP, Sampaio LO, Nader HB. 2009. Heparan sulfate proteoglycans: structure, protein interactions and cell signaling. Ann. Acad. Bras. Cienc. 81:409-429. http://dx .doi.org/10.1590/S0001-37652009000300007.
14. Halbert CL, Allen JM, Miller AD. 2001. Adeno-associated virus type 6 (AAV6) vectors mediate efficient transduction of airway epithelial cells in mouse lungs compared to that of AAV2 vectors. J. Virol. 75:6615-6624. http://dx.doi.org/10.1128/JVI.75.14.6615-6624.2001.
15. Schmidt M, Voutetakis A, Afione S, Zheng C, Mandikian D, Chiorini JA. 2008. Adeno-associated virus type 12 (AAV12): a novel AAV serotype with sialic acid-and heparan sulfate proteoglycan-independent transduction activity. J. Virol. 82:1399-1406. http://dx.doi.org/10.1128/JVI.02012-07.
16. Walters RW, Yi SM, Keshavjee S, Brown KE, Welsh MJ, Chiorini JA, Zabner J. 2001. Binding of adeno-associated virus type 5 to 2,3-linked sialic acid is required for gene transfer. J. Biol. Chem. 276:20610-20616. http://dx.doi.org/10.1074/jbc.M101559200.
17. Varki A, Schauer R. 2009. Sialic acids, p 199-218. In Varki A, Cummings RD, Esko JD, Freeze HH, Stanley P, Bertozzi CR, HartGW,EtzlerME(ed), Essentials of glycobiology, 2nd ed. Cold Spring Harbor Press, Cold Spring Harbor, NY.
18. Walters RW, Pilewski JM, Chiorini JA, Zabner J. 2002. Secreted and transmembrane mucins inhibit gene transfer with AAV4 more efficiently than AAV5. J. Biol. Chem. 277:23709-23713. http://dx.doi.org/10.1074 /jbc.M200292200.
19. Grimm D, Kay MA, Kleinschmidt JA. 2003. Helper virus-free, optically controllable, and two-plasmid-based production of adeno-associated virus vectors of serotypes 1 to 6. Mol. Ther. 7:839-850. http://dx.doi.org/10 .1016/S1525-0016(03)00095-9.
20. Aslanidi G, Lamb K, Zolotukhin S. 2009. An inducible system for highly efficient production of recombinant adeno-associated virus (rAAV) vectors in insect Sf9 cells. Proc. Natl. Acad. Sci. U. S. A. 106:5059-5064. http: //dx.doi.org/10.1073/pnas.0810614106.
21. Winter K, von Kietzell K, Heilbronn R, Pozzuto T, Fechner H, Weger S. 2012. Roles of E4orf6 and VA I RNA in adenovirus-mediated stimulation of human parvovirus B19 DNA replication and structural gene expression. J. Virol. 86:5099-5109. http://dx.doi.org/10.1128/JVI.06991-11.
22. Mietzsch M, Grasse S, Zurawski C, Weger S, Bennett A, Agbandje-McKenna M, Muzyczka N, Zolotukhin S, Heilbronn R. OneBac: platform for scalable and high-titer production of AAV serotype 1-12 vectors for gene therapy. Hum. Gene Ther. http://dx.doi.org/10.1089/hum.2013.184.
23. Noti C, de Paz JL, Polito L, Seeberger PH. 2006. Preparation and use of microarrays containing synthetic heparin oligosaccharides for the rapid analysis of heparin-protein interactions. Chemistry 12:8664-8686. http: //dx.doi.org/10.1002/chem.200601103.
24. de Paz JL, Spillmann D, Seeberger PH. 2006. Microarrays of heparin oligosaccharides obtained by nitrous acid depolymerization of isolated heparin. Chem. Commun. 29:3116-3118. http://dx.doi.org/10.1039/B605318A.
25. Wistuba A, Kern A, Weger S, Grimm D, Kleinschmidt JA. 1997. Subcellular compartmentalization of adeno-associated virus type 2 assembly. J. Virol. 71:1341-1352.
26. Yin J, Seeberger PH. 2010. Applications of heparin and heparan sulfate microarrays. Methods Enzymol. 478:197-218. http://dx.doi.org/10.1016 /S0076-6879(10)78009-5.
27. Lerch TF, Chapman MS. 2012. Identification of the heparin binding site on adeno-associated virus serotype 3B (AAV-3B). Virology 423:6-13. http://dx.doi.org/10.1016/j.virol.2011.10.007.
28. Opie SR, Warrington KH, Jr, Agbandje-McKenna M, Zolotukhin S, Muzyczka N. 2003. Identification of amino acid residues in the capsid proteins of adeno-associated virus type 2 that contribute to heparan sulfate proteoglycan binding. J. Virol. 77:6995-7006. http://dx.doi.org/10 .1128/JVI.77.12.6995-7006.2003.
29. Messina EL, Nienaber J, Daneshmand M, Villamizar N, Samulski J, Milano C, Bowles DE. 2012. Adeno-associated viral vectors based on serotype 3b use components of the fibroblast growth factor receptor signaling complex for efficient transduction. Hum. Gene Ther. 23:1031-1042. http://dx.doi.org/10.1089/hum.2012.066.
30. Blackburn SD, Steadman RA, Johnson FB. 2006. Attachment of adenoassociated virus type3Hto fibroblast growth factor receptor 1. Arch. Virol. 151:617-623. http://dx.doi.org/10.1007/s00705-005-0650-6.
31. Ling C, Lu Y, Kalsi JK, Jayandharan GR, Li B, Ma W, Cheng B, Gee SW, McGoogan KE, Govindasamy L, Zhong L, Agbandje-McKenna M, Srivastava A. 2010. Human hepatocyte growth factor receptor is a cellular coreceptor for adeno-associated virus serotype 3. Hum. Gene Ther. 21: 1741-1747. http://dx.doi.org/10.1089/hum.2010.075.
32. Zincarelli C, Soltys S, Rengo G, Rabinowitz JE. 2008. Analysis of AAV serotypes 1-9 mediated gene expression and tropism in mice after systemic injection. Mol. Ther. 16:1073-1080. http://dx.doi.org/10.1038/mt.2008.76.
33. Stanley P, Cummings RD. 2009. Structures common to different glycans, p 175-198. In Varki A, Cummings RD, Esko JD, Freeze HH, Stanley P, Bertozzi CR, Hart GW, Etzler ME (ed), Essentials of glycobiology, 2nd ed. Cold Spring Harbor Press, Cold Spring Harbor, NY.
34. Stanley P, Schachter H, Taniguchi N. 2009. N-glycans, p 101-114. In Varki A, Cummings RD, Esko JD, Freeze HH, Stanley P, Bertozzi CR, Hart GW, Etzler ME (ed), Essentials of glycobiology, 2nd ed. Cold Spring Harbor Press, Cold Spring Harbor, NY.
35. Shen S, Troupes AN, Pulicherla N, Asokan A. 2013. Multiple roles for sialylated glycans in determining the cardiopulmonary tropism of adenoassociated virus 4. J. Virol. 87:13206-13213. http://dx.doi.org/10.1128 /JVI.02109-13.
36. Bishop JR, Schuksz M, Esko JD. 2007. Heparan sulphate proteoglycans fine-tune mammalian physiology. Nature 446:1030-1037. http://dx.doi .org/10.1038/nature05817.
37. Lerch TF, Xie Q, Chapman MS. 2010. The structure of adeno-associated virus serotype 3B (AAV-3B): insights into receptor binding and immune evasion. Virology 403:26-36. http://dx.doi.org/10.1016/j.virol.2010.03.027.
38. Zhang F, Aguilera J, Beaudet JM, Xie Q, Lerch TF, Davulcu O, Colon W, Chapman MS, Linhardt RJ. 2013. Characterization of interactions between heparin/glycosaminoglycan and adeno-associated virus. Biochemistry 52:6275-6285. http://dx.doi.org/10.1021/bi4008676.
39. Esko JD, Sharon N. 2009. Microbial lectins: hemagglutinins, adhesins, and toxins, p 489-500. In Varki A, Cummings RD, Esko JD, Freeze HH, Stanley P, Bertozzi CR, Hart GW, Etzler ME (ed), Essentials of glycobiology, 2nd ed. Cold Spring Harbor Press, Cold Spring Harbor, NY.
40. Brisson JR, Vinogradov E, McNally DJ, Khieu NH, Schoenhofen IC, Logan SM, Jarrell H. 2010. The application of NMR spectroscopy to functional glycomics. Methods Mol. Biol. 600:155-173. http://dx.doi.org /10.1007/978-1-60761-454-8_11.
41. Shen S, Bryant KD, Brown SM, Randell SH, Asokan A. 2011. Terminal N-linked galactose is the primary receptor for adenoassociated virus 9. J. Biol. Chem. 286:13532-13540. http://dx.doi.org /10.1074/jbc.M110.210922.
42. Harvey DJ, Merry AH, Royle L, Campbell MP, Dwek RA, Rudd PM. 2009. Proposal for a standard system for drawing structural diagrams of N-and O-linked carbohydrates and related compounds. Proteomics 9:3796-3801. http://dx.doi.org/10.1002/pmic.200900096.